vs
Consensus Cloud Solutions, Inc.（CCSI）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
Consensus Cloud Solutions, Inc.的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.5倍（$88.5M vs $60.1M），Consensus Cloud Solutions, Inc.净利率更高（27.9% vs -92.6%，领先120.5%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 1.5%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 0.6%）
Consensus Cloud Solutions是一家云解决方案提供商，核心产品包括加密数字传真、安全文档交换、工作流程自动化工具，主要面向医疗、法律、金融服务等领域的北美企业客户提供相关服务。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
CCSI vs RYTM — 直观对比
营收规模更大
CCSI
是对方的1.5倍
$60.1M
营收增速更快
RYTM
高出82.3%
1.5%
净利率更高
CCSI
高出120.5%
-92.6%
两年增速更快
RYTM
近两年复合增速
0.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $88.5M | $60.1M |
| 净利润 | $24.7M | $-55.6M |
| 毛利率 | 80.9% | 88.1% |
| 营业利润率 | 42.7% | -87.1% |
| 净利率 | 27.9% | -92.6% |
| 营收同比 | 1.5% | 83.8% |
| 净利润同比 | 16.7% | — |
| 每股收益（稀释后） | $1.30 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCSIRYTM
| Q1 26 | $88.5M | $60.1M | ||
| Q4 25 | $87.1M | $57.3M | ||
| Q3 25 | $87.8M | $51.3M | ||
| Q2 25 | $87.7M | $48.5M | ||
| Q1 25 | $87.1M | $32.7M | ||
| Q4 24 | $87.0M | $41.8M | ||
| Q3 24 | $87.8M | $33.3M | ||
| Q2 24 | $87.5M | $29.1M |
净利润CCSIRYTM
| Q1 26 | $24.7M | $-55.6M | ||
| Q4 25 | $20.5M | $-47.5M | ||
| Q3 25 | $22.1M | $-52.9M | ||
| Q2 25 | $20.8M | $-46.6M | ||
| Q1 25 | $21.2M | $-49.5M | ||
| Q4 24 | $18.1M | $-43.3M | ||
| Q3 24 | $21.1M | $-43.6M | ||
| Q2 24 | $23.9M | $-32.3M |
毛利率CCSIRYTM
| Q1 26 | 80.9% | 88.1% | ||
| Q4 25 | 80.0% | 91.6% | ||
| Q3 25 | 80.0% | 89.3% | ||
| Q2 25 | 79.9% | 88.6% | ||
| Q1 25 | 79.3% | 88.8% | ||
| Q4 24 | 79.5% | 90.9% | ||
| Q3 24 | 79.9% | 88.5% | ||
| Q2 24 | 80.4% | 89.9% |
营业利润率CCSIRYTM
| Q1 26 | 42.7% | -87.1% | ||
| Q4 25 | 41.1% | -82.2% | ||
| Q3 25 | 43.2% | -102.6% | ||
| Q2 25 | 44.5% | -93.4% | ||
| Q1 25 | 43.0% | -143.7% | ||
| Q4 24 | 38.4% | -98.6% | ||
| Q3 24 | 43.8% | -132.0% | ||
| Q2 24 | 45.6% | -139.2% |
净利率CCSIRYTM
| Q1 26 | 27.9% | -92.6% | ||
| Q4 25 | 23.5% | -83.0% | ||
| Q3 25 | 25.2% | -103.1% | ||
| Q2 25 | 23.7% | -96.1% | ||
| Q1 25 | 24.3% | -151.4% | ||
| Q4 24 | 20.8% | -103.6% | ||
| Q3 24 | 24.1% | -131.2% | ||
| Q2 24 | 27.3% | -110.9% |
每股收益（稀释后）CCSIRYTM
| Q1 26 | $1.30 | $-0.83 | ||
| Q4 25 | $1.06 | $-0.73 | ||
| Q3 25 | $1.15 | $-0.82 | ||
| Q2 25 | $1.07 | $-0.75 | ||
| Q1 25 | $1.07 | $-0.81 | ||
| Q4 24 | $0.92 | $-0.71 | ||
| Q3 24 | $1.09 | $-0.73 | ||
| Q2 24 | $1.24 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $92.3M | $340.6M |
| 总债务越低越好 | $556.8M | — |
| 股东权益账面价值 | $22.0M | $122.9M |
| 总资产 | $678.7M | $442.3M |
| 负债/权益比越低杠杆越低 | 25.31× | — |
8季度趋势，按日历期对齐
现金及短期投资CCSIRYTM
| Q1 26 | $92.3M | $340.6M | ||
| Q4 25 | $74.7M | $388.9M | ||
| Q3 25 | $97.6M | $416.1M | ||
| Q2 25 | $57.9M | $291.0M | ||
| Q1 25 | $53.4M | $314.5M | ||
| Q4 24 | $33.5M | $320.6M | ||
| Q3 24 | $54.6M | $298.4M | ||
| Q2 24 | $49.2M | $319.1M |
总债务CCSIRYTM
| Q1 26 | $556.8M | — | ||
| Q4 25 | $558.4M | — | ||
| Q3 25 | $578.6M | — | ||
| Q2 25 | $578.2M | — | ||
| Q1 25 | $583.7M | — | ||
| Q4 24 | $593.0M | — | ||
| Q3 24 | $612.5M | — | ||
| Q2 24 | $642.8M | — |
股东权益CCSIRYTM
| Q1 26 | $22.0M | $122.9M | ||
| Q4 25 | $13.8M | $139.1M | ||
| Q3 25 | $-2.6M | $148.8M | ||
| Q2 25 | $-26.5M | $-11.9M | ||
| Q1 25 | $-49.4M | $18.9M | ||
| Q4 24 | $-79.5M | $21.7M | ||
| Q3 24 | $-93.2M | $11.2M | ||
| Q2 24 | $-124.4M | $39.3M |
总资产CCSIRYTM
| Q1 26 | $678.7M | $442.3M | ||
| Q4 25 | $663.8M | $480.2M | ||
| Q3 25 | $675.0M | $506.9M | ||
| Q2 25 | $641.5M | $372.7M | ||
| Q1 25 | $629.6M | $386.7M | ||
| Q4 24 | $602.2M | $392.3M | ||
| Q3 24 | $622.5M | $363.6M | ||
| Q2 24 | $608.5M | $381.8M |
负债/权益比CCSIRYTM
| Q1 26 | 25.31× | — | ||
| Q4 25 | 40.54× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.8M | — |
| 自由现金流经营现金流 - 资本支出 | $38.5M | — |
| 自由现金流率自由现金流/营收 | 43.5% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $110.6M | — |
8季度趋势，按日历期对齐
经营现金流CCSIRYTM
| Q1 26 | $45.8M | — | ||
| Q4 25 | $15.2M | $-25.4M | ||
| Q3 25 | $51.6M | $-26.6M | ||
| Q2 25 | $28.3M | $-23.3M | ||
| Q1 25 | $40.9M | $-40.4M | ||
| Q4 24 | $11.1M | $-18.8M | ||
| Q3 24 | $41.6M | $-25.2M | ||
| Q2 24 | $24.4M | $-29.1M |
自由现金流CCSIRYTM
| Q1 26 | $38.5M | — | ||
| Q4 25 | $7.3M | — | ||
| Q3 25 | $44.4M | — | ||
| Q2 25 | $20.3M | — | ||
| Q1 25 | $33.7M | — | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $33.6M | — | ||
| Q2 24 | $15.8M | — |
自由现金流率CCSIRYTM
| Q1 26 | 43.5% | — | ||
| Q4 25 | 8.4% | — | ||
| Q3 25 | 50.6% | — | ||
| Q2 25 | 23.2% | — | ||
| Q1 25 | 38.7% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | 38.3% | — | ||
| Q2 24 | 18.1% | — |
资本支出强度CCSIRYTM
| Q1 26 | — | — | ||
| Q4 25 | 9.1% | — | ||
| Q3 25 | 8.2% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 9.8% | — |
现金转化率CCSIRYTM
| Q1 26 | 1.86× | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.94× | — | ||
| Q4 24 | 0.62× | — | ||
| Q3 24 | 1.97× | — | ||
| Q2 24 | 1.02× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
